GlaxoSmithKline's departure of a key scientist to a de-aging start-up puts the pharma behemoth on the defensive.
⬆Links to an external web page: click to leave
Up-vote or down-vote this result.
a little different search engine
You've arrived at result 2371919
Links to an external web page: click to leave
Up-vote or down-vote this result.